Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02237157
Title A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors RenovoRx
Indications

pancreatic cancer

Therapies

Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.